| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
138,140,000 |
| Market
Cap: |
142.28(M) |
| Last
Volume: |
3,241,097 |
Avg
Vol: |
3,311,042 |
| 52
Week Range: |
$0.937 - $1.31 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Drug Manufacturers - Major |
|
Member Indexes:
|
| |
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : 807 |
| Guru Rank Value : 1 |
| Guru Occurances : 1 |
|
|
|
|
|
| |
|
Company Profile Spectrum Pharmaceuticals is a biopharmaceutical company. Co. is engaged in acquiring, developing, and commercializing targeted oncology therapies. Co. has two drugs in late-stage development: Eflapegrastim, which is a long-acting granulocyte colony-stimulating factor for the treatment of chemotherapy-induced neutropenia; as well as Poziotinib, which is an irreversible tyrosine kinase inhibitor under investigation for non-small cell lung cancer tumors with various mutations.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
50,000 |
| Total Buy Value |
$0 |
$0 |
$0 |
$22,500 |
| Total People Bought |
0 |
0 |
0 |
1 |
| Total Buy Transactions |
0 |
0 |
0 |
1 |
| Total Shares Sold |
0 |
0 |
32,387 |
490,738 |
| Total Sell Value |
$0 |
$0 |
$35,496 |
$343,474 |
| Total People Sold |
0 |
0 |
1 |
7 |
| Total Sell Transactions |
0 |
0 |
1 |
19 |
| End Date |
2024-02-11 |
2023-11-10 |
2023-05-12 |
2022-05-12 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Gagnon Gilles |
Director |
– • – |
2018-06-18 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
82,500 |
|
- |
|
| Maida Anthony E III |
Director |
– • – |
2018-06-18 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
32,988 |
|
- |
|
| Vyas Dolatrai |
Director |
– • – |
2018-06-18 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
47,079 |
|
- |
|
| Ashton William |
Director |
– • – |
2018-06-18 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
10,000 |
|
- |
|
| Cohen Raymond W |
Director |
– • – |
2018-06-18 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
38,850 |
|
- |
|
| Lenaz Luigi Md |
Director |
– • – |
2018-05-22 |
4 |
OE |
$1.47 |
$58,800 |
D/D |
40,000 |
109,077 |
|
- |
|
| Krassner Stuart Mitchell |
Director |
– • – |
2018-05-17 |
4 |
S |
$18.94 |
$399,880 |
D/D |
(21,113) |
57,944 |
|
- |
|
| Shrotriya Rajesh C Md |
Director |
– • – |
2018-05-17 |
4 |
GA |
$0.00 |
$0 |
I/I |
362,926 |
978,889 |
|
- |
|
| Shrotriya Rajesh C Md |
Director |
– • – |
2018-05-17 |
4 |
GD |
$0.00 |
$0 |
D/D |
362,926 |
200,652 |
|
- |
|
| Shrotriya Rajesh C Md |
Director |
– • – |
2018-05-17 |
4 |
OE |
$1.43 |
$529,001 |
D/D |
362,926 |
563,578 |
|
- |
|
| Cohen Raymond W |
Director |
– • – |
2018-05-14 |
4 |
S |
$18.32 |
$169,918 |
D/D |
(9,275) |
28,850 |
|
- |
|
| Riga Thomas J |
EVP, COO & CCO |
• – – |
2018-05-14 |
4 |
AS |
$18.10 |
$59,552 |
D/D |
(3,290) |
240,498 |
|
- |
|
| Shrotriya Rajesh C Md |
Director |
– • – |
2018-05-14 |
4 |
AS |
$18.38 |
$441,377 |
I/I |
(24,014) |
615,963 |
|
- |
|
| Shrotriya Rajesh C Md |
Director |
– • – |
2018-05-11 |
4 |
AS |
$17.55 |
$526,500 |
I/I |
(30,000) |
639,977 |
|
- |
|
| Shrotriya Rajesh C Md |
Director |
– • – |
2018-05-10 |
4 |
AS |
$17.13 |
$513,900 |
I/I |
(30,000) |
669,977 |
|
- |
|
| Shrotriya Rajesh C Md |
Director |
– • – |
2018-05-09 |
4 |
AS |
$16.21 |
$486,300 |
I/I |
(30,000) |
699,977 |
|
- |
|
| Shrotriya Rajesh C Md |
Director |
– • – |
2018-05-08 |
4 |
AS |
$16.11 |
$483,300 |
I/I |
(30,000) |
729,977 |
|
- |
|
| Shrotriya Rajesh C Md |
Director |
– • – |
2018-05-07 |
4 |
AS |
$15.98 |
$479,400 |
I/I |
(30,000) |
759,977 |
|
- |
|
| Shrotriya Rajesh C Md |
Director |
– • – |
2018-05-04 |
4 |
AS |
$16.79 |
$503,700 |
I/I |
(30,000) |
789,977 |
|
- |
|
| Shrotriya Rajesh C Md |
Director |
– • – |
2018-05-03 |
4 |
AS |
$16.01 |
$480,300 |
I/I |
(30,000) |
819,977 |
|
- |
|
| Shrotriya Rajesh C Md |
Director |
– • – |
2018-05-02 |
4 |
AS |
$16.04 |
$481,200 |
I/I |
(30,000) |
849,977 |
|
- |
|
| Shrotriya Rajesh C Md |
Director |
– • – |
2018-05-01 |
4 |
AS |
$15.77 |
$473,100 |
I/I |
(30,000) |
879,977 |
|
- |
|
| Shrotriya Rajesh C Md |
Director |
– • – |
2018-04-30 |
4 |
AS |
$16.36 |
$490,800 |
I/I |
(30,000) |
909,977 |
|
- |
|
| Shrotriya Rajesh C Md |
Director |
– • – |
2018-04-27 |
4 |
AS |
$17.17 |
$515,100 |
I/I |
(30,000) |
939,977 |
|
- |
|
| Shrotriya Rajesh C Md |
Director |
– • – |
2018-04-26 |
4 |
AS |
$17.26 |
$517,800 |
I/I |
(30,000) |
969,977 |
|
- |
|
658 Records found
|
|
Page 11 of 27 |
|
|
